Chimera Investment Corporation
CIM
$13.62
-$0.08-0.58%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.46M | 11.65M | 2.71M | -- | -- |
| Total Other Revenue | 291.82M | 315.11M | 275.17M | 442.34M | 306.43M |
| Total Revenue | 312.28M | 326.75M | 277.88M | 442.34M | 306.43M |
| Cost of Revenue | 29.40M | 29.56M | 29.79M | 30.13M | 30.93M |
| Gross Profit | 282.88M | 297.19M | 248.09M | 412.21M | 275.49M |
| SG&A Expenses | 74.81M | 69.63M | 64.57M | 53.75M | 53.49M |
| Depreciation & Amortization | 2.22M | 1.27M | 321.00K | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 106.43M | 100.46M | 94.68M | 83.88M | 84.42M |
| Operating Income | 205.85M | 226.30M | 183.21M | 358.46M | 222.00M |
| Income Before Tax | 194.87M | 215.70M | 176.11M | 353.18M | 218.95M |
| Income Tax Expenses | 2.17M | 1.80M | 49.00K | 57.00K | 116.00K |
| Earnings from Continuing Operations | 192.69 | 213.91 | 176.07 | 353.12 | 218.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 192.69M | 213.91M | 176.07M | 353.12M | 218.83M |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 1.31 | 1.56 | 1.13 | 3.35 | 1.73 |
| Normalized Basic EPS | 1.49 | 1.65 | 1.37 | 2.76 | 1.72 |
| EPS Diluted | 1.27 | 1.51 | 1.10 | 3.32 | 1.71 |
| Normalized Diluted EPS | 1.46 | 1.62 | 1.34 | 2.73 | 1.70 |
| Average Basic Shares Outstanding | 325.22M | 325.14M | 325.03M | 320.03M | 314.80M |
| Average Diluted Shares Outstanding | 328.50M | 328.18M | 327.50M | 323.72M | 317.45M |
| Dividend Per Share | 1.48 | 1.46 | 1.42 | 1.38 | 1.55 |
| Payout Ratio | 122.43% | 107.50% | 126.80% | 60.64% | 89.62% |